Clinical trials by condition

Hidradenitis suppurativa (HS) clinical trials near you

28 studies for hidradenitis suppurativa (HS) are recruiting volunteers at 285 research sites in 41 states.

Also called Hidradenitis suppurativa (Skin disorder).

Studies recruiting
28
Research sites
285
States
41

What is hidradenitis suppurativa (HS)?

Hidradenitis suppurativa (HS), also called acne inversa, is a long-lasting skin disease. It causes painful, boil-like lumps under the skin, often where skin rubs together, such as the armpits and groin. The lumps become inflamed, often break open and drain fluid and pus, and can leave scars as they heal.

The lumps form when hair follicles become blocked and trap bacteria, which leads to inflammation. In most cases the cause of the blockages is unknown; genetics, environment and hormones may play a role. HS is not caused by poor hygiene and cannot spread to others. It usually starts after puberty.

Treatments focus on the symptoms and depend on how severe the disease is. They may include medicines such as antibiotics, steroids and medicines that fight inflammation, biologics, procedures or surgery to remove the lumps and scars, and, in early stages, laser hair removal.

Written with AI from MedlinePlus, the National Library of Medicine's health information, and checked by an AI medical reviewer on November 13, 2026. Read more on MedlinePlus

Areas with the most hidradenitis suppurativa (HS) studies

Metro areas where studies for hidradenitis suppurativa (HS) are recruiting, each study counted once in an area.

  1. 1New YorkNew York10 studies
  2. 2BostonMassachusetts9 studies
  3. 3MiamiFlorida9 studies
  4. 4Los AngelesCalifornia8 studies
  5. 5HoustonTexas7 studies
  6. 6AtlantaGeorgia6 studies
  7. 7BirminghamAlabama6 studies
  8. 8ChicagoIllinois6 studies
  9. 9PhoenixArizona6 studies
  10. 10TampaFlorida6 studies

By state

Studies for hidradenitis suppurativa (HS) recruiting in each state.

  • California12 studies · 27 sites
  • Florida10 studies · 45 sites
  • Massachusetts10 studies · 13 sites
  • New York9 studies · 17 sites
  • Texas9 studies · 20 sites
  • Georgia8 studies · 13 sites
  • Indiana7 studies · 9 sites
  • Alabama6 studies · 7 sites
  • Arizona6 studies · 9 sites
  • Illinois6 studies · 10 sites
All 41 states

Whom the studies accept

The share of the hidradenitis suppurativa (HS) studies open to each group. A study can accept several.

  • Adults 18 to 6496%
  • Adults 65 and over93%
  • Children and teens (under 18)21%
  • Healthy volunteers11%
  • Open to all sexes96%
  • Women only4%

Study phases

Earlier phases test safety in fewer people; later phases compare a treatment with the usual care in many.

  • Early phase 111%
  • Phase 118%
  • Phase 232%
  • Phase 37%
  • No phase (device, behavioral and other studies)11%
  • Not stated21%

Cite these figures

Free to use under CC BY 4.0. Please credit LocalTrial with a link to this page.

As text

Source: LocalTrial, Hidradenitis suppurativa (HS) clinical trials near you, https://www.localtrial.com/clinical-trials/conditions/hidradenitis-suppurativa, updated November 13, 2026.

With the link, for a web page

Source: <a href="https://www.localtrial.com/clinical-trials/conditions/hidradenitis-suppurativa">LocalTrial, Hidradenitis suppurativa (HS) clinical trials near you</a>, updated November 13, 2026.

About these figures

Counted from ClinicalTrials.gov, the U.S. registry of clinical studies, for studies recruiting in the United States that study hidradenitis suppurativa (HS). A study is counted once however many sites it has.

Updated November 13, 2026.

These figures describe studies, not advice. Talk to your doctor before joining one.

Tell us a little about yourself and we'll suggest the hidradenitis suppurativa (HS) studies near you that may fit. Free and private.

Find hidradenitis suppurativa (HS) studies near me
Hidradenitis suppurativa (HS) Clinical Trials Near Me | LocalTrial